Adtalem Global Education (ATGE, Financial) has received a Buy rating from Jefferies, which has set a price target of $135 on the stock. This favorable evaluation stems from the firm's belief that Adtalem is well-positioned to benefit from a persistent shortfall in healthcare labor supply, potentially leading to sustained market growth in the sector.
Jefferies analysts emphasize that Adtalem features a unique profile in terms of free cash flow and share buybacks. Additionally, the company is operating with a straightforward setup, supported by conservative guidance, suggesting potential for its shares to continue appreciating.
Investors are being advised that Adtalem represents an attractive option to capitalize on the healthcare sector's long-term growth prospects.
